drugset / Trial / NCT01019655

Heparin for Pregnant Women With Thrombophilia

NCT01019655

Phase 3 Unknown 300 enrolled Medical University of Vienna
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to investigate whether heparin is an effective treatment in pregnant women at risk for thrombosis and other pregnancy-associated complications.

Timeline

Start
2010-01
Primary completion
2012-01
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Nadroparin Calcium Other / unclassified 0.3 ml